MaxCyte Statistics

Total Valuation

MaxCyte has a market cap or net worth of GBP 276.36 million. The enterprise value is 175.26 million.

Market Cap	276.36M
Enterprise Value	175.26M

Important Dates

The last earnings date was Wednesday, November 6, 2024.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

MaxCyte has 105.48 million shares outstanding. The number of shares has increased by 1.47% in one year.

Current Share Class	n/a
Shares Outstanding	105.48M
Shares Change (YoY)	+1.47%
Shares Change (QoQ)	+0.45%
Owned by Insiders (%)	1.28%
Owned by Institutions (%)	63.29%
Float	95.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.04
PB Ratio	1.73
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.57
EV / Sales	5.15
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.07

Financial Position

The company has a current ratio of 9.81, with a Debt / Equity ratio of 0.09.

Current Ratio	9.81
Quick Ratio	8.99
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	-0.86
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -16.00% and return on invested capital (ROIC) is -12.05%.

Return on Equity (ROE)	-16.00%
Return on Assets (ROA)	-11.25%
Return on Capital (ROIC)	-12.05%
Revenue Per Employee	237,912
Profits Per Employee	-186,452
Employee Count	143
Asset Turnover	0.18
Inventory Turnover	0.56

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.52% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-15.52%
50-Day Moving Average	288.96
200-Day Moving Average	327.61
Relative Strength Index (RSI)	37.52
Average Volume (20 Days)	59,853

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MaxCyte had revenue of GBP 34.02 million and -26.66 million in losses. Loss per share was -0.26.

Revenue	34.02M
Gross Profit	29.25M
Operating Income	-34.61M
Pretax Income	-26.66M
Net Income	-26.66M
EBITDA	-31.36M
EBIT	-34.61M
Loss Per Share	-0.26

Full Income Statement

Balance Sheet

The company has 114.77 million in cash and 13.67 million in debt, giving a net cash position of 101.11 million or 0.96 per share.

Cash & Cash Equivalents	114.77M
Total Debt	13.67M
Net Cash	101.11M
Net Cash Per Share	0.96
Equity (Book Value)	159.14M
Book Value Per Share	1.51
Working Capital	115.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.03 million and capital expenditures -1.80 million, giving a free cash flow of -15.84 million.

Operating Cash Flow	-14.03M
Capital Expenditures	-1.80M
Free Cash Flow	-15.84M
FCF Per Share	-0.15

Full Cash Flow Statement

Margins

Gross margin is 85.98%, with operating and profit margins of -101.74% and -78.37%.

Gross Margin	85.98%
Operating Margin	-101.74%
Pretax Margin	-78.37%
Profit Margin	-78.37%
EBITDA Margin	-92.18%
EBIT Margin	-101.74%
FCF Margin	-46.55%

Dividends & Yields

MaxCyte does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.47%
Shareholder Yield	-1.47%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MaxCyte has an Altman Z-Score of 6.72.

Altman Z-Score	6.72
Piotroski F-Score	n/a